nbc news semaglutide FDA approves pill version of Wegovy: What you need to know In the original clinical trials

A 2021 review of studies noted that digestive side effects like nausea are often mild to moderate and tend to sharply decrease after week 20 of treatment

Medical nutrition therapy and weight loss questions for the evidence analysis library prevention of type 2 diabetes project: systematic reviews

10.1111/j.1469-7793.1997.333bh.x 54 ShibasakiT.TakahashiH.MikiT.SunagaY.MatsumuraK.YamanakaM.et al (2007)

Psychological and behavioural risks : Combining multiple weight loss interventions may foster unhealthy relationships with food, promote disordered eating patterns, and create unrealistic expectations about sustainable weight management

Tolerability: Side effects are generally mild to moderate, predominantly gastrointestinal, and mirror the safety profile expected with injectable treatments

Meghan V